Metabolic characterization of AIDS dementia complex by spectroscopic imaging

Prospective proton chemical shift imaging (CSI) of the brain was performed in 30 HIV‐1‐seropositive patients and 11 healthy controls. Significant (P < 0.05) reductions in the N‐acetyl‐L‐aspartate (NAA)/total creatine (Cr), and NAA/total choline (Cho) ratios and significant increases in Cho/Cr occurred in patients with 1) AIDS‐defining diagnoses; 2) <200 CD4 lymphocyte counts/μl; 3) neurological evidence for an AIDS dementia complex (ADC); 4) magnetic resonance imaging (MRI) signs of cerebral atrophy. The basal ganglia and the insula were affected to approximately the same extent and without indications of spatial variations within these areas. Reduced NAA seems to indicate progressive neuronal injury or loss due to productive HIV infection in the brain and its clinical picture ADC. Spectroscopic abnormalities were, however, also observed in neurologically normal HIV patients or those with normal MRI results. Proton CSI may therefore serve as an early quantitative marker of central nervous system involvement in AIDS. J. Magn. Reson. Imaging 1999;9:10–18 © 1999 Wiley‐Liss, Inc.

[1]  T. Hung,et al.  A percutaneous balloon catheter for the immediate control of hemorrhage. , 1970, Radiology.

[2]  J. Cooper,et al.  N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.

[3]  Roger J. Ordidge,et al.  THE CORRECTION OF TRANSIENT B0 FIELD SHIFTS FOLLOWING THE APPLICATION OF PULSED GRADIENTS BY PHASE CORRECTION IN THE TIME DOMAIN , 1986 .

[4]  C. Cordon-Cardo,et al.  HIV antigen in the brains of patients with the AIDS dementia complex , 1987, Annals of neurology.

[5]  S. Strother,et al.  The metabolic pathology of the AIDS dementia complex , 1987, Annals of neurology.

[6]  R. Kauppinen,et al.  Brain metabolites as 1H NMR markers of neuronal and glial disorders , 1989, NMR in biomedicine.

[7]  D. Menon,et al.  Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. , 1990, Journal of computer assisted tomography.

[8]  C. Hardy,et al.  AIDS dementia complex: brain high-energy phosphate metabolite deficits. , 1990, Radiology.

[9]  P. Lantos,et al.  Neuronal loss in the frontal cortex in HIV infection , 1991, The Lancet.

[10]  E. Masliah,et al.  Neocortical damage during HIV infection , 1991, Annals of neurology.

[11]  I. Husstedt,et al.  Event-related potentials in HIV-infected outpatients. , 1991, AIDS research and human retroviruses.

[12]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[13]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[14]  A. J. Kumar,et al.  Patterns of cerebral atrophy in HIV–1–infected individuals , 1992, Neurology.

[15]  E. Masliah,et al.  Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.

[16]  B. Gelman,et al.  Morphometry, histopathology, and tomography of cerebral atrophy in the acquired immunodeficiency syndrome , 1992, Annals of neurology.

[17]  D. Menon,et al.  Proton MR Spectroscopy of the Brain in AIDS Dementia Complex , 1992, Journal of computer assisted tomography.

[18]  G. D. Pearlson,et al.  Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.

[19]  P. Lantos,et al.  Neuronal number and volume alterations in the neocortex of HIV infected individuals. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[20]  I. Wilkinson,et al.  Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. , 1993, Radiology.

[21]  R. Lenkinski,et al.  Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. , 1993, Radiology.

[22]  G. Fein,et al.  Reduced brain N‐acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus‐seropositive individuals , 1993, Neurology.

[23]  I. Wilkinson,et al.  Localized cerebral proton MR spectroscopy in HIV infection and AIDS. , 1994, AJNR. American journal of neuroradiology.

[24]  G. Fein,et al.  N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals. , 1994, Magnetic resonance imaging.

[25]  H. Gendelman,et al.  Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. , 1994, AIDS research and human retroviruses.

[26]  J. Vion-Dury,et al.  Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy , 1995, The Lancet.

[27]  I. Wilkinson,et al.  Short echo time proton spectroscopy of the brain in HIV infection/AIDS. , 1995, Magnetic resonance imaging.

[28]  P. Barker,et al.  AIDS dementia complex: evaluation with proton MR spectroscopic imaging. , 1995, Radiology.

[29]  S. Pavlakis,et al.  Magnetic resonance spectroscopy in childhood AIDS encephalopathy. , 1995, Pediatric neurology.

[30]  B D Ross,et al.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.

[31]  I. Wilkinson,et al.  A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. , 1996, AIDS research and human retroviruses.

[32]  S. Pavlakis,et al.  Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. , 1996, Radiology.

[33]  J. Hennig,et al.  HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. , 1996, Radiology.

[34]  S. Evers,et al.  Event-related potentials in HIV infection: evidence for impact of antiretroviral treatment. , 1996, Archives of neurology.

[35]  Y. Lamontagne,et al.  Three‐dimensional electromagnetic field computation by the multiscalar boundary element method , 1996 .

[36]  A. Guimarães,et al.  Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex , 1996, Neurology.

[37]  J. Catalan,et al.  Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection , 1997, AIDS.

[38]  P. Renshaw,et al.  Elevated frontal lobe cytosolic choline levels in minimal or mild AIDS dementia complex patients: A proton magnetic resonance spectroscopy study , 1997, Biological Psychiatry.